Abstract
FRI-335 - Loss of HbsAg is enough to discontinue long-term therapy with Nucleos(T)ide analogues in HbeAg negative CHB patients in real clinical practice?
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have